Peter Schmid FRCP, MD, PhD

Prof. Peter Schmid was appointed as Chair in Cancer Medicine at Barts Cancer Institute in 2013. He is Lead of the Centre of Experimental Cancer Medicine at Barts and of the joint Barts/Brighton Experimental Cancer Medicine Centre. He also leads the academic breast and lung cancer programmes at Barts. Prof. Schmid joined Barts from the University of Sussex, where he was appointed as Foundation Chair in Cancer Medicine in 2010. Prof. Schmid studied medicine in Munich and Aberdeen. He was awarded scholarships by the 'Studienstiftung des Deutschen Volkes', the 'Hanns-Seidel-Foundation', and the 'Deutscher Akademischer Austauschdienst'. Prof. Schmid completed an MD on mitochondrial creatine kinase at the Technical University Munich. He trained at the University Hospital Charite in Berlin in internal medicine, hematology, and oncology, where he became head of breast cancer research and the phase I programme. He completed his Ph.D. at the Charite in 2005. From 2005-2010, Prof. Schmid was a Senior Clinical Lecturer & Director of the Hammersmith Early Clinical Trials Unit at Imperial College London. Prof. Schmid’s specialist cancer interests are breast and lung cancer and early drug development.